Lung cancer is one of the leading causes of cancer‑associated mortality. C‑reactive protein
(CRP), albumin (ALB), globulin (GLB), lactate dehydrogenase (LDH), neutrophil‑lymphocyte …

Method: One hundred fifteen patients with locally advanced and advanced lung cancer who
were diagnosed in our chest diseases clinic between 2013 and 2015 were retrospectively …

Lung cancer remains the leading cause of cancer-related deaths worldwide, with non-small
cell lung cancer (NSCLC) accounting for the vast majority. In recent years, the interaction …

Aim Systemic inflammatory response is closely related to tumor progression. We
retrospectively investigated relationships between systemic inflammatory scores, C‐reactive …

Chemotherapy is widely administered to patients with advanced lung cancer; however, data
regarding chemotherapeutic sensitivity are limited. The present study aimed to investigate …

Aim: To compare and evaluate the prognostic value of various pretreatment combinations of
inflammatory factors in patients with lung cancer (LC). Materials & methods: This study …

Background Previous study of ours showed that advanced lung cancer inflammation index
(ALI) and C-reactive protein (CRP) are independent significant prognostic factors in …

OBJECTIVES The usefulness of a recently developed advanced lung cancer inflammation
index (ALI) has been reported in advanced non-small-cell lung cancer (NSCLC) and small …

Systemic inflammatory response markers are associated with poor survival in many types of
malignances. This study aimed to evaluate the prognostic value of preoperative neutrophil …

Objective: Inflammation has been validated as a host-related prognostic marker in cancer.
The Glasgow Prognostic score (GPS) and neutrophil-to-lymphocyte ratio (NLR) are …